New Product Pairing Enhances Pathologists’ Ability To Confirm Diagnoses And Improve Productivity
Elsevier, the leading publisher of health science information products and services, announced today that it has entered into an agreement to offer its PathConsult online diagnosis resource tool through mTuitive’s xPert for Pathology™ system, bundling two powerful knowledge- and technology-based products. The agreement empowers pathologists to maximize the accuracy and efficiency of their diagnoses by providing access to the advanced information resources of PathConsult to xPert for Pathology™ users.
"The addition of PathConsult is a great enhancement to xPert for Pathology and we are proud to be associated with this first-class international publishing firm," states John Murphy, CEO of mTuitive. "PathConsult contains tremendous context sensitive resources that enhances the knowledge xPert for Pathology aims to deliver to pathologists when they need it."
mTuitive’s xPert for Pathology™ is an interactive software product for quickly and easily reporting malignant tumors according to the College of American Pathologists’ protocols. The product provides expert guidance, error checks and complete documentation, with the aim of standardizing practice and providing knowledge to the practitioner at critical decision times. PathConsult is an Elsevier clinical decision support tool that provides the latest clinical content, along with thousands of images, in an online resource allowing professionals to quickly get the diagnostic information they need, exactly when they need it.
"This agreement reflects Elsevier’s commitment to deliver a truly innovative tool for customers and end-users," said Randy Charles, Executive Vice President, Clinical Solutions, for Elsevier. "It is a reflection of the commitment and dedication that the two organizations have to develop the latest workflow tools for improving the quality and effectiveness of healthcare delivery."
For more information, visit http://www.PathConsultDDX.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.
Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About mTuitive
mTuitive, Inc. develops data capture and synoptic reporting software to assist health care professionals in recording clinical findings and maintaining compliance with established protocols and guidelines. Our unique method of capturing structured information provides valuable data for pathology, oncology, and cancer staging applications. Our products allow the clinical decision-maker to conveniently receive alerts and reference materials directly at the point of care. mTuitive software improves care to the patient through quality assurance and error reduction while standardizing and automating manual reporting processes, reducing both time and labor costs. Established in 2003, mTuitive, Inc. is based in Massachusetts. See us on the Web at www.mtuitive.com.
